| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.0061 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |